| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/18/2009 | CA2404616C Use of vegf and homologues to treat neuron disorders |
| 08/18/2009 | CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 08/18/2009 | CA2224008C The treatment of hiv and other viral infections using combinatorial therapy |
| 08/18/2009 | CA2223691C Tumor- or cell-specific herpes simplex virus replication |
| 08/18/2009 | CA2215697C Stable polymerized hemoglobin blood-substitute |
| 08/18/2009 | CA2184841C Recombinant adenovirus coding for glial-derived neurotrophic factor (gdnf) |
| 08/18/2009 | CA2105552C Soluble ligands for cd40 |
| 08/18/2009 | CA2054798C Hcv-specific peptides, agents therefor and the use thereof |
| 08/13/2009 | WO2009100384A2 Heterooligomeric serotonin/glutamate receptor complex |
| 08/13/2009 | WO2009100360A1 Stabilization of the collagen triple helix by o-methylation of hydroxyproline residues |
| 08/13/2009 | WO2009100255A2 Modified leptin polypeptides and their uses |
| 08/13/2009 | WO2009100127A2 Isolated brca1 peptides and method of use |
| 08/13/2009 | WO2009100102A2 Ts23 alpha-amylase variants with altered properties |
| 08/13/2009 | WO2009100035A2 Interleukin-21 (il-21) and il-21 receptor (il-21r) modulation of regulatory t cells and forkhead box p3 (foxp3) |
| 08/13/2009 | WO2009099749A1 Use of plastid transit peptides derived from glaucocystophytes |
| 08/13/2009 | WO2009099631A1 Novel plasminogen receptor, polypeptides & antibodies thereof |
| 08/13/2009 | WO2009099561A2 Urinary ca125 peptides as biomarkers of ovarian cancer |
| 08/13/2009 | WO2009099378A1 Selection of rna-aptamers as anti-malaria agents |
| 08/13/2009 | WO2009099204A1 Method and kit for detection of anti-avibacterium paragallinarum antibody |
| 08/13/2009 | WO2009099098A1 Anti-fungal substance |
| 08/13/2009 | WO2009098700A1 Siva 3, its preparation and use |
| 08/13/2009 | WO2009098682A2 Methods and compositions for treatment of mitochondrial disorders |
| 08/13/2009 | WO2009098656A2 Method for predicting or diagnosing outcome of intracranial tumors in a subject |
| 08/13/2009 | WO2009098344A1 Compositions and methods for modulating p300 activity |
| 08/13/2009 | WO2009098321A1 Use of adiponectin for the diagnosis and/or treatment of presbycusis |
| 08/13/2009 | WO2009098277A1 Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines |
| 08/13/2009 | WO2009098246A1 Recombinant bacteria with e. coli hemolysin secretion system and increased expression and/or secretion of hlya, process of manufacturing and uses thereof |
| 08/13/2009 | WO2009098196A2 Molecular targets and compounds, methods to identify the same, useful in the treatment of neurodegenerative diseases. |
| 08/13/2009 | WO2009098094A1 Process for the production of biologically active hiv-1 tat protein |
| 08/13/2009 | WO2009097692A1 Biomarkers for head-and-neck cancers and precancers |
| 08/13/2009 | WO2009097691A1 USE OF P27kip1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE |
| 08/13/2009 | WO2009097684A1 Method and device for measuring the temperature of a hot spot in an oil-containing electric apparatus |
| 08/13/2009 | WO2009081274A3 Mutant forms of streptolysin o |
| 08/13/2009 | WO2009078712A3 Light-driven co2 reduction to organic compounds to serve as fuels or as industrial half products by an autotroph containing a fermentative gene cassette |
| 08/13/2009 | WO2009073460A3 Inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 for ocular neuroprotection |
| 08/13/2009 | WO2009067191A3 Methods and compositions for the treatment of hepatitis c virus (hcv) infection |
| 08/13/2009 | WO2009061853A3 Mutant interleukin-2 (il-2) polypeptides |
| 08/13/2009 | WO2009050573A3 Viral modification of reoviridae |
| 08/13/2009 | WO2009047513A3 Antagonists of kisspeptin and uses thereof |
| 08/13/2009 | WO2009044173A3 Methods of treating cancer using notch pathway inhibitors |
| 08/13/2009 | WO2009016515A3 Compositions comprising pneumococcal antigens |
| 08/13/2009 | WO2009016456A3 Idiotypic vaccine |
| 08/13/2009 | WO2008148839A3 Long-acting polymeric prodrugs of exendin |
| 08/13/2009 | WO2003003984A8 Novel proteins and nucleic acids encoding same |
| 08/13/2009 | US20090205087 Modified Cry34 Proteins |
| 08/13/2009 | US20090205085 Nucleotide and amino acid sequences from Xenorhabdus bovienii strain Xs85831 and uses thereof |
| 08/13/2009 | US20090205084 Nucleotide and amino acid sequences from xenorhabdus and uses thereof |
| 08/13/2009 | US20090205083 Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genes |
| 08/13/2009 | US20090205077 Compositions and methods for the modification of gene expression |
| 08/13/2009 | US20090205075 Use of plastid transit peptides derived from glaucocystophytes |
| 08/13/2009 | US20090205072 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
| 08/13/2009 | US20090205071 a polynucleotide and a genetic vector comprising the polynucleotide, used for introgressing genes into grass plants, so as to provide desirable drought resistant cultivars of plants |
| 08/13/2009 | US20090205061 Taste Receptors Of The T1R Family From Domestic Cat |
| 08/13/2009 | US20090203888 Isolated Photoprotein Aqdecay, and Its Use |
| 08/13/2009 | US20090203887 Novel Centromeric Protein Shugoshin |
| 08/13/2009 | US20090203885 Astrocyte Modulated Genes And Uses Thereof |
| 08/13/2009 | US20090203883 Mussel bioadhesive |
| 08/13/2009 | US20090203882 Novel microbial enzymes and their use |
| 08/13/2009 | US20090203879 Activated labeling reagents and methods for preparing and using the same |
| 08/13/2009 | US20090203878 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 08/13/2009 | US20090203803 N-acylated chitinous polymers and methods of use thereof |
| 08/13/2009 | US20090203760 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 08/13/2009 | US20090203635 HXAAA01 Polynucleotides |
| 08/13/2009 | US20090203620 Methods for attenuating release of inflammatory mediators and peptides useful therein |
| 08/13/2009 | US20090203618 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification |
| 08/13/2009 | US20090203617 Chimeric peptides for the regulation of gtpases |
| 08/13/2009 | US20090203615 Use of activity dependent neurotrophic factor for enhancing learning and memory: pre-and post-natal administration |
| 08/13/2009 | US20090203612 toxin complex (TC) genes and proteins obtainable from Xenorhabdus strain Xwi; exochitinase obtainable from the Xwi strain used to control insects |
| 08/13/2009 | US20090203611 Anti-microbial defensin-related peptides and methods of use |
| 08/13/2009 | US20090203608 reducing lipid accumulation in an adipocyte; finding a therapeutic agents for treating obesity, diabetes, arteriosclerosis |
| 08/13/2009 | US20090203602 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 08/13/2009 | US20090203600 Pharmaceutical composition for the prophylaxis and treatment of hiv infection and its use |
| 08/13/2009 | US20090203599 N-terminal modified peg-trail, method for preparing and uses thereof |
| 08/13/2009 | US20090203598 Abc transporter ligand |
| 08/13/2009 | US20090203596 Phosphatase Inhibitor Protein-1 As A Regulator of Cardiac Function |
| 08/13/2009 | US20090203595 Neuregulin variants and methods of screening and using thereof |
| 08/13/2009 | US20090203593 Immunogenic Constructs |
| 08/13/2009 | US20090203588 Outcome prediction and risk classification in childhood leukemia |
| 08/13/2009 | US20090203587 Diagnosis and Therapy of Cell Proliferative Disorders Characterized by Resistance to Trail Induced Apoptosis |
| 08/13/2009 | US20090203586 Method for ameliorating an inflammatory skin condition |
| 08/13/2009 | US20090203584 Peptide-based Compounds |
| 08/13/2009 | US20090203582 Lysobactin amides |
| 08/13/2009 | US20090203580 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity |
| 08/13/2009 | US20090203579 Glycopegylated Granulocyte Colony Stimulating Factor |
| 08/13/2009 | US20090203575 metabolic diseases such as lysosomal storage diseases; therapeutic agent and a targeting moiety that binds a mannose-6-phosphate receptor |
| 08/13/2009 | US20090203572 Method for in Vitro Molecular Evolution of Protein Function |
| 08/13/2009 | US20090203541 Msp and its domains as frameworks for novel binding molecules |
| 08/13/2009 | US20090203144 Hiv-gag codon-optimised dna vaccines |
| 08/13/2009 | US20090203134 Remedy for nerve cell regeneration |
| 08/13/2009 | US20090203128 Nogo-Receptors and Methods of Use |
| 08/13/2009 | US20090203124 Mage-a3 peptides presented by hla-dr1 molecules |
| 08/13/2009 | US20090203123 for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 08/13/2009 | US20090203122 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/13/2009 | US20090203114 Novel methods and interferon deficient substrates for the propagation of viruses |
| 08/13/2009 | US20090203113 comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; drug delivery |
| 08/13/2009 | US20090203093 Protein Targeting To Lipid Bodies |
| 08/13/2009 | US20090203074 Bacillus Host Cell |
| 08/13/2009 | US20090203049 Beta integrin gene and protein |
| 08/13/2009 | US20090203046 Methods for identifying purkinje cells using the corl2 gene as a target |
| 08/13/2009 | US20090203042 Novel bt toxin receptors from lepidopteran insects and methods of use |